This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format

Tiffany Lucas
Gene Therapy CMC Product Reviewer, Biologist at FDA


Gene Therapies Branch CMC reviewers conduct scientific review, interpretation, and documentation of product manufacturing data to evaluate the safety and quality of gene therapy products in regulatory submissions, regulatory reviews of regulatory submissions, guidance and policy development activities in gene therapy and genetic editing. The Gene Therapies Branch in Division of Cellular and Gene Therapies (DCGT), Office of Tissues and Advanced Therapies, is located within the Center for Biologics Evaluation and Research (CBER). Experienced laboratory scientist in virology, retroviral and lentiviral gene therapy vectors, immunology, medical entomology, tissue imaging, infectious disease, and insect model systems.

Speakers at this event